Screening for diabetes mellitus in patients with OSAS: a case for glycosylated haemoglobin

Fitzgerald Deirdre B., Kent Brian D., Garvey John F., Russell Audrey, Nolan Geraldine, McNicholas Walter T.

Source: Eur Respir J 2012; 40: 273-274
Journal Issue: July

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fitzgerald Deirdre B., Kent Brian D., Garvey John F., Russell Audrey, Nolan Geraldine, McNicholas Walter T.. Screening for diabetes mellitus in patients with OSAS: a case for glycosylated haemoglobin. Eur Respir J 2012; 40: 273-274

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of COPD patients with and without diabetes mellitus
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


A study of the comorbidity of COPD and type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007


Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus>
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008

Control of ventilation in patients with insulin-dependent diabetes mellitus complicated by autonomic neuropathy
Source: Eur Respir J 2005; 26: Suppl. 49, 66s
Year: 2005

Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 222s
Year: 2004

Development of diabetes mellitus in patients with bronchial asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008

Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012


The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004

Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients
Source: Eur Respir J 2007; 30: Suppl. 51, 365s
Year: 2007

Influence of the glycaemic control [HbA1c] on sleep disorders reported by 261 obese type 2 diabetic patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Measurment of lung diffusion capacity in patients with diabetes mellitus
Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases
Year: 2009


Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012

Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus
Source: International Congress 2017 – COPD management
Year: 2017

Cheyne-stokes-respiration is an independent modulator of systolic blood pressure in patients with diabetes mellitus type 2
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017